Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Antria, Inc. logo — Pioneering the future of regenerative medicine and cellular...

Antria, Inc.

Pioneering the future of regenerative medicine and cellular therapies across a wide expanse of medical specialties.

Founded 2011 6 employees Venture round Total: $1.44M Biotechnology, Health Care

General Information

Company Name Antria, Inc.
Founded Year 2011
Founders / Decision Makers
Team member
Employees 6
Industries Biotechnology, Health Care
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with Antria, Inc.. To contact Antria, Inc., visit antria.org.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About Antria, Inc.

Antria, Inc. is a biotechnology startup founded in 2011 that focuses on pioneering the future of regenerative medicine and cellular therapies across various medical specialties. The company specializes in the development of innovative cellular therapies for cosmetic applications, chronic medical conditions, and diseases impacting millions of patients globally. With a $1.44M Venture Round investment on 29 January 2013, it continues to make strides in the biotechnology and healthcare industries, attracting attention from potential investors. Antria, Inc. is poised to make significant contributions to the advancement of medical treatments and is a promising prospect for venture capital investment.

Taxonomy: regenerative medicine, cellular therapies, clinical research organization, stem cells, platelet-rich plasma, cosmetic surgery, reconstructive surgery, neurology, cardiology, orthopedics, internal medicine, chronic wounds, breast cancer, multiple sclerosis

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round $1.44M -
29 Jan 2013

Antria, Inc. Alternatives & Competitors

Antria, Inc. vs
Angiocrine Bioscience, Inc.
Angiocrine Bioscience, Inc. United States

Transforming medicine through engineered cellular therapies that restore, regenerate, and repair tis...

Grant
21 employees
Biotechnology, Health Care
Antria, Inc. vs
NeuroGenesis Bio Inc.
NeuroGenesis Bio Inc. United States

Cell Therapies for Neurodegenerative Diseases

Series A
10 employees
Biotechnology, Health Care
Antria, Inc. vs
Minerva Biotechnologies
Minerva Biotechnologies United States

We see the future first

17 employees
Biotechnology, Health Care

FAQ About Antria, Inc.

Pioneering the future of regenerative medicine and cellular therapies across a wide expanse of medical specialties.
Antria, Inc. was founded in 2011.
Antria, Inc. operates in Biotechnology and Health Care. Its work centres on regenerative medicine, cellular therapies, clinical research organization and stem cells.
Antria, Inc. has approximately 6 employees.
Antria, Inc. has completed 1 funding round, raising a total of $1.44M. The latest funding stage is Venture round.
Top alternatives and competitors to Antria, Inc. include Angiocrine Bioscience, Inc., NeuroGenesis Bio Inc., Minerva Biotechnologies, The Texas Heart Institute, Harvard Apparatus Regenerative Technology, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Antria, Inc. and Angiocrine Bioscience, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Antria, Inc., https://bouncewatch.com/company/antria-inc, updated 20 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes